Innovus Pharmaceuticals Inc Aktie OTC Bulletin Board
Aktien
US45778V1061
Pharmazeutika
Schlusskurs
Andere Börsenplätze
|
||
- USD | - |
Manager | Titel | Alter | Seit |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01.06.18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
% 1. Jan. | Kap. | |
---|---|---|
+40.73% | 739 Mrd. | |
+32.83% | 598 Mrd. | |
-6.30% | 353 Mrd. | |
+15.15% | 318 Mrd. | |
+4.05% | 285 Mrd. | |
+15.00% | 240 Mrd. | |
-5.52% | 206 Mrd. | |
+6.17% | 164 Mrd. | |
-0.45% | 162 Mrd. |